Jump to navigation Jump to search
Pharmaceutical grade L-glutamine
Diseases for which it is used
History of changes in FDA indication
- 7/7/2017: Approved for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder.
Also known as
- Brand name: Endari